References
- Béji S, Kaaroud H, Ben Moussa F, Goucha R, Abderrahim
E, El Younsi F, Ben Maïz H. Amylose rénale compliquant l’évolution de colites
inflammatoires chroniques. Presse Med. 2004 Jul 31;33(13):862-5. Google
Scholar
- Wendling D, Humbert P, Hory B, Blanc D, Dupond JL, Guidet
M. Le rein de la maladie de Still de l’adulte. Rev Rhum Mal Osteoartic. 1989
Mar 15;56(4):325-7.
- Harrington TM, Moran JJ, Davis DE. Amyloidosis in adult
onset Still’s disease. J Rheumatol. 1981 Sep-Oct;8(5):833-6.
- Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al. Preliminary criteria for classification of adult still’s disease. J Rheumatol. 1992 Mar;19(3):424-30. PubMed | Google Scholar
- Katia Stankovic, Gilles Grateau. Amylose AA. Néphrologie & Thérapeutique.
2008 Jul;4(4):281-7.
- Vigneron AM, Kaplan G, Labrouse C, Leroux-Roret C, Réné E,
Kahn MF. Amylose au cours de la maladie de Still de l’adulte: à propos de deux
observations. Ann Med Int. 1986;137(5):406-8.
- Ben Ghorbel I, Khanfir M, Houman MH. Amylose rénale compliquant une maladie de Still de l’adulte. Rev Med Int. 2004 Sep;25(9):675-7. PubMed | Google Scholar
- Kchir MM, Abid F, Hajri R, Abdelmoula L, Ben Moussa F,
Zouari R. Amylose au cours de la maladie de Still de l’adulte: intérêt du traitement
par cyclophosphamide. Ann Med Interne. 1998 Dec;149(8):527-9.
- Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H et al. Adult Still’s disease: a multicenter survey of Japanese patients. J Rheumatol. 1990 Aug;17(8):1058-63. PubMed | Google Scholar
- Cabane J, Michon A, Ziza JM, Bourgois P, Blétry O, Godeau
P et al. Comparison of long term evolution of adult onset and Still’s
disease, both followed-up for more than ten years. Ann Rheum Dis. 1990 May;49(5):283-5. Google
Scholar
- Tejera B, Martínez-Morillo M, Holgado S, Olivé A. Secondary amyloidosis in adult onset Still's disease. Med Clin (Barc). 2014 Jul 22;143(2):92-3. PubMed | Google Scholar
- Lachmann HJ, Goodman HJB, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007 Jun 7;356(23):2361-71. PubMed | Google Scholar
- Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001 Jul 7;358(9275):24-9. PubMed | Google Scholar
- Fatihi E, Ramdani B, Fadel H, Hachim K, Zahiri K, Benghanem GM et al. Prévalence des lésions
amyloïdes sous-cutanées, labiale et rectale chez des patients ayant une amylose
rénale confirmée histologiquement. Néphrologie. 2000;21(1):19-21. Google
Scholar
- Ortiz-Santamaria V, Olive A, Valls-Roc M, Tena X. Treatment of AA amyloid with Chlorambucil. Rheumatology (Oxford). 2002;41:833. PubMed | Google Scholar
- Chevrel G, Jenvrin C, McGregor B, Miossec P. Renal type
AA amyloidosis associated with rheumatoid arthritis: a cohort study showing
improved survival on treatment with pulse cyclophosphamide. Rheumatology (Oxford).
2001;40:821-5. Google
Scholar
- Fernández-Nebro A, Olivé A, Castro MC, Varela AH, Riera E, Irigoyen MV et al. Long-term TNF alpha blockade in patients with amyloid A amyloidosis complicating rheumatic diseases. Am J Med. 2010;123(5):454-61. PubMed | Google Scholar
- Serratrice J, Granel B, Disdier P, Weiller PJ, Dussol B. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease. Am J Med. 2003;115(7):589-90. PubMed | Google Scholar
- Fernandez-Nebro A, Tomero E, Ortiz-Santamaria V, Castro MC, Olive A, De Haro M et al. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am J Med. 2005;118:552-6. Google Scholar
- Kishida D, Okuda Y, Onishi M, Takebayashi M, Matoba K,
Jouyama K et al. Successful tocilizumab treatment in a patient with
adult-onset Still's disease complicated by chronic activehepatitis B and amyloid
A amyloidosis. Mod Rheumatol. 2011;21(2):215-8. Google
Scholar